In the context of a Lanham Act case, CRA assessed whether market performance for a hospital-based pharmaceutical product was affected by alleged improper statements by a competitor. CRA’s causality analysis included consideration of other economic factors that affected product sales, including assessment of market preparation, launch, commercialization, and promotional efforts used to support the product that was allegedly affected by improper marketing support.
The Media Show - Reporting on the Abuse of Power
Philip Marsden discusses some of the ramifications of the UK Government’s approach to Digital Regulation, ahead of the Queen’s Speech this week. For more...